PMC:7784830 / 22471-22686 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7784830","sourcedb":"PMC","sourceid":"7784830","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7784830","text":"Entos Pharmaceuticals Fusogenix – DNA vaccine is being developed based on its patent protected platform, proteo-lipid vehicle (PLV). It uses a new mechanism for delivering genetic material into the cells [105,106]","divisions":[{"label":"td","span":{"begin":0,"end":21}},{"label":"td","span":{"begin":23,"end":204}}],"tracks":[{"project":"LitCovid-sentences","denotations":[{"id":"T174","span":{"begin":0,"end":133},"obj":"Sentence"},{"id":"T175","span":{"begin":134,"end":215},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T174","pred":"source","obj":"LitCovid-sentences"},{"subj":"T175","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-sentences","color":"#b593ec","default":true}]}]}}